Margaret Guidici

These wide-moat healthcare stocks are trading below our analysts’ fair value estimates in 2023.

The bear market has left a large number of cyclical stocks trading at attractive prices.

High-quality names such as Veeva, Medtronic, Pfizer, and Kellogg are trading at discounted prices.

Semiconductor stocks took a beating in 2022, leaving many names trading at a discount.

High-quality tech stocks, including Microsoft, Salesforce, and Workday, are trading below their fair value estimates.

Tech stocks such as Apple, Nvidia, Block, and Lattice Semiconductor are fueling the growth stock rally in 2023.

These stocks are trading at attractive prices after losing a battle to the bear market.

After an up-and-down ride, many of these dividend-paying stocks are at attractive prices.

These stocks from the Morningstar US Biotechnology Index look cheap.

Veeva, Clorox, and Kellogg are among the defensive stocks trading below our analysts’ fair value estimates.